110 related articles for article (PubMed ID: 11481089)
1. [Imipenem/cilastatin-induced acute thrombocytopenia].
Alegre Herrera S; Quirós Valera M; Rodríguez Fernández A
Med Clin (Barc); 2001 Jul; 117(5):197-8. PubMed ID: 11481089
[No Abstract] [Full Text] [Related]
2. Worsening of myasthenia gravis on treatment with imipenem/cilastatin.
O'Riordan J; Javed M; Doherty C; Hutchinson M
J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):383. PubMed ID: 8158196
[No Abstract] [Full Text] [Related]
3. Imipenem cilastatin sodium-associated thrombocytopenia in an older patient: A case report and literature review.
Qiao W; Chang C; Wang Q; Cao X; Zhang X
Int J Clin Pharmacol Ther; 2022 Aug; 60(8):358-363. PubMed ID: 35652550
[TBL] [Abstract][Full Text] [Related]
4. Severe neutropenia in a patient treated with imipenem/cilastatin.
Fariñas MC; de Vega T; Garmendia J; González-Macías J
Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):303-4. PubMed ID: 8513823
[No Abstract] [Full Text] [Related]
5. Vertigo caused by intravenous imipenem/cilastatin.
Duque A; Altimiras J; García-Cases C; Vidal P
DICP; 1991 Sep; 25(9):1009. PubMed ID: 1949961
[No Abstract] [Full Text] [Related]
6. Lack of cross-reactivity to meropenem in a patient with an allergy to imipenem-cilastatin.
Bauer SL; Wall GC; Skoglund KJ; Peters LK
J Allergy Clin Immunol; 2004 Jan; 113(1):173-5. PubMed ID: 14713926
[No Abstract] [Full Text] [Related]
7. Imipenem-cilastatin induced pure white cell aplasia.
Kalambokis G; Vassou A; Bourantas K; Tsianos EV
Scand J Infect Dis; 2005; 37(8):619-620. PubMed ID: 16138439
[TBL] [Abstract][Full Text] [Related]
8. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin.
Karadeniz C; Oğuz A; Canter B; Serdaroğlu A
Pediatr Hematol Oncol; 2000; 17(7):585-90. PubMed ID: 11033734
[TBL] [Abstract][Full Text] [Related]
9. Seizures related to use of imipenem-cilastatin.
Lane M; Kania D; Rapp RP
Am J Health Syst Pharm; 1996 Jul; 53(13):1605-6. PubMed ID: 8809285
[No Abstract] [Full Text] [Related]
10. Safe use of imipenem/cilastatin in a neonatal intensive care unit.
Lee SY; Chow CB
Acta Paediatr Jpn; 1998 Apr; 40(2):186-7. PubMed ID: 9581316
[No Abstract] [Full Text] [Related]
11. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin.
Guglielmo BJ; Jacobs RA
Am J Health Syst Pharm; 1996 Sep; 53(17):2097-8. PubMed ID: 8870902
[No Abstract] [Full Text] [Related]
12. Imipenem/cilastatin-induced acute eosinophilic pneumonia.
Foong KS; Lee A; Pekez M; Bin W
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26944380
[TBL] [Abstract][Full Text] [Related]
13. Risk/benefit in the treatment of children with imipenem-cilastatin for meningitis caused by penicillin-resistant pneumococcus.
Asensi F; Otero MC; Pérez-Tamarit D; Rodríguez-Escribano I; Cabedo JL; Gresa S; Cantón E
J Chemother; 1993 Apr; 5(2):133-4. PubMed ID: 8515296
[TBL] [Abstract][Full Text] [Related]
14. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
[TBL] [Abstract][Full Text] [Related]
15. Imipenem/cilastatin treatment of bacterial meningitis in children.
Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS
Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603
[TBL] [Abstract][Full Text] [Related]
16. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
[TBL] [Abstract][Full Text] [Related]
17. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Eklund AE; Nord CE
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
[TBL] [Abstract][Full Text] [Related]
18. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group.
Norrby SR; Finch RG; Glauser M
J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130
[TBL] [Abstract][Full Text] [Related]
19. Seizure activity associated with imipenem use: clinical case reports and review of the literature.
Leo RJ; Ballow CH
DICP; 1991 Apr; 25(4):351-4. PubMed ID: 1926901
[TBL] [Abstract][Full Text] [Related]
20. Prolonged continuous i.v. "desensitization" in Tienam hypersensitivity.
Confino-Cohen R; Goldberg A; Lang R
Allergy; 1997 Jun; 52(6):683-4. PubMed ID: 9226072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
